BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38687350)

  • 21. Efficacy of intraperitoneal and intravenous chemotherapy for advanced gastric cancer with peritoneal metastasis.
    Chen Y; Wang XJ; Lin RB; Chen L; Lin G; Guo ZQ
    Tumori; 2014; 100(5):e180-8. PubMed ID: 25343556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake.
    Hara H; Kadowaki S; Asayama M; Ooki A; Yamada T; Yoshii T; Yamaguchi K
    Int J Clin Oncol; 2018 Apr; 23(2):275-280. PubMed ID: 29039072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study.
    Tahara M; Ohtsu A; Boku N; Nagashima F; Muto M; Sano Y; Yoshida M; Mera K; Hironaka S; Tajiri H; Yoshida S
    Gastric Cancer; 2001; 4(4):212-8. PubMed ID: 11846065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of multidetector-row CT in the preoperative prediction of peritoneal metastasis from gastric cancer: a single-center and large-scale study].
    Yan C; Zhu ZG; Yan M; Chen KM; Chen J; Xiang M; Chen MM; Liu BY; Yin HR; Lin YZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):106-10. PubMed ID: 20186619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
    Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer.
    Liu S; He J; Liu S; Ji C; Guan W; Chen L; Guan Y; Yang X; Zhou Z
    Eur Radiol; 2020 Jan; 30(1):239-246. PubMed ID: 31385045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
    Guo J; Deng Z; Jin L; Yin S; Xiong Z; Wang C; Chen H; Luo D; Huang D; Peng J; Chen S; Lian L
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17881-17896. PubMed ID: 37947869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments.
    Santullo F; Ferracci F; Abatini C; Halabieh MAE; Lodoli C; D'Annibale G; Di Cesare L; D'Agostino L; Pecere S; Di Giorgio A; Strippoli A; Pacelli F
    Langenbecks Arch Surg; 2023 Nov; 408(1):437. PubMed ID: 37973620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of effective treatment with chemosensitivity test-guided chemotherapy for advanced pancreatic and gastric cancer with peritoneal metastasis].
    Shinchi H; Maemura K; Noma H; Mataki Y; Kurahara H; Maeda S; Kitazono M; Nakashima H; Maenohara S; Natsugoe S; Takao S
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):1009-12. PubMed ID: 18633235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of contrast-enhanced CT of the peritoneum to evaluate efficacy of neoadjuvant chemotherapy for peritoneal dissemination in an advanced gastric cancer case].
    Ohtani M; Takayama S; Ogata N; Sekine C; Nimura H; Tsutsumi J; Kashimura H; Sano Y; Inoue Y; Aoki T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1837-40. PubMed ID: 8937495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
    Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
    Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study.
    Inal A; Kaplan MA; Kuçukoner M; Urakci Z; Guven M; Nas N; Yunce M; Işikdogan A
    Asian Pac J Cancer Prev; 2012; 13(8):3869-72. PubMed ID: 23098485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.
    Ishigami H; Kitayama J; Kaisaki S; Hidemura A; Kato M; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Nagawa H
    Ann Oncol; 2010 Jan; 21(1):67-70. PubMed ID: 19605503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and diagnostic significance of abdominal CT for peritoneal metastases in patients with primary gastric cancer].
    Yoshikawa T; Kanari M; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1925-8. PubMed ID: 12465391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis.
    Guo JC; Chang CC; Yang CY; Liao BC; Liau JY; Chang CH; Yeh KH
    Med Oncol; 2017 Aug; 34(8):143. PubMed ID: 28726044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
    Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
    Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
    Okabe H; Ueda S; Obama K; Hosogi H; Sakai Y
    Ann Surg Oncol; 2009 Dec; 16(12):3227-36. PubMed ID: 19777180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.